Non-invasive medical devices to treat some of the worlds greatest health concerns.

FDA-cleared. Prescription required.

Making Life Better

The reality is you don’t need another fad, and we’re not here to sell you hype. We’re here to deliver proven methods and treatments backed by science using the power of neurostimulation — the power of your brain. We’re here to help you feel better and address disorders you previously treated with quick fixes, trendy diets, and medications with side effects. You deserve better.

Welcome to Neurovalens, where real wellness begins.

Better Sleep In Just 4 Weeks

An FDA Cleared home use treatment for Chronic Insomnia.

What does this graph show?

* Individual results may vary

Your Health. Our Technology

Our mission is to Make Life Better. We understand that living with chronic health conditions can greatly impact your daily life. Many medications and treatments come with side effects that can prevent you from reaching your full potential and living the life you want.

Modius technology puts your health and wellbeing first, helping you live your best life.

Deisgned by neurologists. Supported by science.

Latest News

Our Type 2 Diabetes Clinical Trial Has Successfully Concluded!

The study tested the safety and effectiveness of a non-drug, non-invasive neurostimulation wearable device designed to help adults with Type 2 Diabetes improve their blood sugar control.

Neurovalens shines at the 2024 Life Science Industry Awards

We are delighted to have been awarded the Small Life Science Company of the Year at the 2024 Life Science Industry Awards, held in Dublin on the 27th of June. The event recognised the most innovative individuals and companies leading excellence in Ireland's life sciences sector.

Neurovalens Appoints Kate Willis as Vice President of Commercialization

Kate Willis has been appointed as the Vice President of Commercialization, where she will oversee the sales of Neurovalens' prescribed medical devices in the US and work towards securing reimbursement approvals from private healthcare insurance providers.

Neurovalens CEO Appointed Visiting Scholar at UC San Diego

Neurovalens CEO, Dr. Jason McKeown has been appointed as a Visiting Scholar at the prestigious University of California, San Diego (UCSD), joining the Department of Psychiatry. This appointment marks a journey that began nearly a decade ago when Jason first collaborated with UCSD.

Read the Modius Sleep Study

You can delve a little deeper into the technology and science behind Modius Sleep, explore the clinical trial results and learn more about the Modius Sleep journey to becoming an FDA cleared treatment for Chronic Insomnia that requires no drugs!

Repeated electrical vestibular nerve stimulation (VeNS) reduces severity in moderate to severe insomnia; a randomised, sham-controlled trial; the modius sleep study

Follow us: